CNCR
ETF Series Solutions Trust Range Cancer Therapeutics ETF
CNCR
CNCR
Delisted
CNCR was delisted on the 27th of May, 2025.
11 hedge funds and large institutions have $1.35M invested in ETF Series Solutions Trust Range Cancer Therapeutics ETF in 2024 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 5 increasing their positions, 2 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
more funds holding
Funds holding: →
0% more first-time investments, than exits
New positions opened: 2 | Existing positions closed: 2
Holders
11
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$414K | |
| 2 | +$205K | |
| 3 | +$9.68K | |
| 4 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$3.16K |
| 5 |
Wells Fargo
San Francisco,
California
|
+$3.08K |
Top Sellers
| 1 | -$17.8K | |
| 2 | -$9K | |
| 3 | -$2.24K | |
| 4 |
CPA
Clear Point Advisors
Melville,
New York
|
-$403 |